Yhb Investment Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Yhb Investment Advisors, Inc.

$1.19 Billion
Q3 2024

A detailed history of Yhb Investment Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 577 shares of REGN stock, worth $436,679. This represents 0.05% of its overall portfolio holdings.

Number of Shares

577

Previous 577 -0.0%

Holding current value

$436,679

Previous $606,000 -0.0%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$902.69 - $993.35 $50,550 - $55,627	-56 Reduced 8.85%	577 $555,000
Q4 2023 Jan 29, 2024	SELL	$775.18 - $881.7 $9,302 - $10,580	-12 Reduced 1.86%	633 $555,000
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $17,311 - $21,109	-25 Reduced 3.73%	645 $530,000
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $25,901 - $30,722	-37 Reduced 5.23%	670 $481,000
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $48,995 - $59,541	-72 Reduced 9.24%	707 $580,000
Q4 2022 Jan 12, 2023	SELL	$705.89 - $766.39 $9,882 - $10,729	-14 Reduced 1.77%	779 $0
Q2 2022 Jul 14, 2022	SELL	$548.35 - $738.84 $5,483 - $7,388	-10 Reduced 1.25%	793 $469,000
Q1 2021 Apr 22, 2021	SELL	$446.73 - $548.2 $4,467 - $5,482	-10 Reduced 1.23%	803 $404,000
Q4 2020 Jan 21, 2021	BUY	$478.3 - $607.98 $1,434 - $1,823	3 Added 0.37%	813 $393,000
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $54,475 - $65,821	-100 Reduced 10.99%	810 $453,000
Q1 2020 Apr 16, 2020	BUY	$336.18 - $494.43 $3,361 - $4,944	10 Added 1.11%	910 $444,000
Q4 2019 Jan 27, 2020	SELL	$274.13 - $376.51 $219,304 - $301,208	-800 Reduced 47.06%	900 $338,000
Q3 2019 Oct 15, 2019	BUY	$273.46 - $318.39 $464,881 - $541,263	1,700 New	1,700 $472,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.

Account

Yhb Investment Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History